Scientific Services
Head of Research Unit
Dr. André Brunella, Dr.
Publications
14 found
Show per page
Willemse, E.A.J. et al. (2025) ‘Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls’, Clinical Chemistry and Laboratory Medicine (CCLM) [Preprint]. Available at: https://doi.org/10.1515/cclm-2025-1480.
Willemse, E.A.J. et al. (2025) ‘Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls’, Clinical Chemistry and Laboratory Medicine (CCLM) [Preprint]. Available at: https://doi.org/10.1515/cclm-2025-1480.
Maceski, Aleksandra Maleska et al. (2025) ‘GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis’, Brain [Preprint]. Available at: https://doi.org/10.1093/brain/awaf433.
Maceski, Aleksandra Maleska et al. (2025) ‘GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis’, Brain [Preprint]. Available at: https://doi.org/10.1093/brain/awaf433.
Sandgren, S. et al. (2025) ‘Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity’, 31. Available at: https://doi.org/10.1177/13524585251375780.
Sandgren, S. et al. (2025) ‘Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity’, 31. Available at: https://doi.org/10.1177/13524585251375780.
Meier, Vincent et al. (2025) ‘Adverse Outcomes in Patients with Atrial Fibrillation and a Pacemaker: A Cohort Study’, Europace [Preprint]. 28.10.2025. Available at: https://doi.org/10.1093/europace/euaf275.
Meier, Vincent et al. (2025) ‘Adverse Outcomes in Patients with Atrial Fibrillation and a Pacemaker: A Cohort Study’, Europace [Preprint]. 28.10.2025. Available at: https://doi.org/10.1093/europace/euaf275.
Bochud, M. et al. (2025) ‘Cohort Profile: Swiss Personalized Health Network Cohort Consortium’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2025.10.10.25337504.
Bochud, M. et al. (2025) ‘Cohort Profile: Swiss Personalized Health Network Cohort Consortium’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2025.10.10.25337504.
Furlan, Roberto et al. (2025) ‘Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis’, Brain [Preprint]. Available at: https://doi.org/10.1093/brain/awaf345.
Furlan, Roberto et al. (2025) ‘Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis’, Brain [Preprint]. Available at: https://doi.org/10.1093/brain/awaf345.
Moschovitis, G. et al. (2025) ‘External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation’, Journal of the American Heart Association, 14. Available at: https://doi.org/10.1161/jaha.125.043058.
Moschovitis, G. et al. (2025) ‘External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation’, Journal of the American Heart Association, 14. Available at: https://doi.org/10.1161/jaha.125.043058.
Yaldizli, Özgür et al. (2025) ‘Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study’, Multiple Sclerosis Journal. 28.04.2025, 31(8), pp. 932–943. Available at: https://doi.org/10.1177/13524585251335466.
Yaldizli, Özgür et al. (2025) ‘Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study’, Multiple Sclerosis Journal. 28.04.2025, 31(8), pp. 932–943. Available at: https://doi.org/10.1177/13524585251335466.
Atila, Cihan et al. (2025) ‘A novel diagnostic score for diagnosing arginine vasopressin deficiency (central diabetes insipidus) or primary polydipsia with basal laboratory and clinical parameters: results from two international multicentre prospective diagnostic studies’, Lancet Diabetes and Endocrinology, 13, pp. 505–515. Available at: https://doi.org/10.1016/s2213-8587(25)00053-1.
Atila, Cihan et al. (2025) ‘A novel diagnostic score for diagnosing arginine vasopressin deficiency (central diabetes insipidus) or primary polydipsia with basal laboratory and clinical parameters: results from two international multicentre prospective diagnostic studies’, Lancet Diabetes and Endocrinology, 13, pp. 505–515. Available at: https://doi.org/10.1016/s2213-8587(25)00053-1.
Alberto, Anthea et al. (2025) ‘Management of Digital Research Data at the End of a Project’. Available at: https://doi.org/10.5281/ZENODO.14925912.
Alberto, Anthea et al. (2025) ‘Management of Digital Research Data at the End of a Project’. Available at: https://doi.org/10.5281/ZENODO.14925912.
Benkert, Pascal et al. (2025) ‘Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis’, Annals of Neurology. 16.10.2024, 97(1), pp. 104–115. Available at: https://doi.org/10.1002/ana.27096.
Benkert, Pascal et al. (2025) ‘Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis’, Annals of Neurology. 16.10.2024, 97(1), pp. 104–115. Available at: https://doi.org/10.1002/ana.27096.
Suter, Katja et al. (2025) ‘Befragung von Personen, die an klinischen Studien teilnehmen – INPUT (INvolvieren von Patient:innen Und Teilnehmenden)’, in 26. Jahrestagung des Netzwerks Evidenzbasierte Medizin e. V. 27.03.2025. Freiburg (26. Jahrestagung des Netzwerks Evidenzbasierte Medizin e. V.). Available at: https://doi.org/10.3205/25ebm076.
Suter, Katja et al. (2025) ‘Befragung von Personen, die an klinischen Studien teilnehmen – INPUT (INvolvieren von Patient:innen Und Teilnehmenden)’, in 26. Jahrestagung des Netzwerks Evidenzbasierte Medizin e. V. 27.03.2025. Freiburg (26. Jahrestagung des Netzwerks Evidenzbasierte Medizin e. V.). Available at: https://doi.org/10.3205/25ebm076.
Kaufmann, Josefin E. et al. (2024) ‘Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis’, JAMA Neurology. 13.05.2024, 81(6), pp. 630–637. Available at: https://doi.org/10.1001/jamaneurol.2024.1141.
Kaufmann, Josefin E. et al. (2024) ‘Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis’, JAMA Neurology. 13.05.2024, 81(6), pp. 630–637. Available at: https://doi.org/10.1001/jamaneurol.2024.1141.
Boesen, K et al. (2024) ‘Rationale and design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A continuously updated clinical trial database of cancer immunotherapies’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.04.26.24306436.
Boesen, K et al. (2024) ‘Rationale and design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A continuously updated clinical trial database of cancer immunotherapies’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.04.26.24306436.